Navigation Links
Adamas Pharmaceuticals Signs CRADA With U.S. Navy to Conduct Preclinical Studies of Triple-Combination Antiviral Drug Therapy for Influenza A, Including the Novel H1N1 Pandemic Strain
Date:8/18/2009

Emeryville, Calif., Aug. 18 /PRNewswire/ -- Adamas Pharmaceuticals, Inc., a privately held company, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Naval Health Research Center for preclinical studies evaluating Adamas' triple combination antiviral drug (TCAD) therapy for influenza A, including novel influenza A/H1N1. TCAD therapy includes Adamas' investigational proprietary fixed-dose oral combination drug, to be administered adjunctively with a neuraminidase inhibitor, including Tamiflu (oseltamivir phosphate, Roche).

Under the CRADA, the U.S. Naval Health Research Center will conduct comparative tests of Adamas' TCAD therapy against various strains of the influenza A virus, including seasonal influenza (H1N1, H3N2), avian influenza (H5N1) and novel influenza A/H1N1. The purpose of these studies is to assess the in vitro activity of TCAD therapy against various circulating and/or highly pathogenic strains of the influenza A virus, as well as to compare the in vitro activity of TCAD therapy to other pharmaceutical agents when used alone or in double combination. Data from these experiments will be used to advance the development of Adamas' TCAD therapy as a potential broad-spectrum antiviral therapy for serious infections caused by influenza A viruses. In addition, Adamas and the Navy's work with the novel influenza A/H1N1 virus may provide insight into this widespread public health issue.

"Collaborating with the U.S. Naval Health Research Center, with its leadership in medicine and its seminal work in discovering the novel influenza A/H1N1 virus, will significantly advance Adamas' efforts to develop TCAD therapy in response to the influenza pandemic," said Gregory Went, Ph.D., Chief Executive Officer and Chairman of Adamas. "We look forward to partnering with the Naval Health Research Center to generate d
'/>"/>

SOURCE Adamas Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial
2. Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
3. Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing
4. Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
5. Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease; Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver Disease and Metabolic Syndrome
6. BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
7. Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences
8. Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
9. Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
10. Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets
11. King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... 1, 2015 The Institute for Healthcare Advancement ... award winners. The IHA Health Literacy Awards aim to ... on the practice of educating or empowering organizations to ... awards in three categories: innovative programs, published materials and ... Hero award. In the area of innovative ...
(Date:5/1/2015)... , May 1, 2015 Semler Scientific, Inc. ... company that develops, manufactures and markets products that assist ... today reported financial results for the first quarter ended ... quarter of 2015, Semler reported continued progress with year ... quarter revenue growth of 14%," said Doug Murphy-Chutorian ...
(Date:5/1/2015)... NEW YORK , May 1, 2015  Shares ... over 70% of their value yesterday following the results ... company,s glaucoma therapy, Rhopressa.  Despite the trial failing to ... indicates that positive results may come from future studies. ... a brief company overview, current pipeline, financial review, analyst ...
Breaking Medicine Technology:Institute for Healthcare Advancement Announces 2015 Award Winners 2Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4Semler Reports First Quarter 2015 Financial Results 5All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2
... LAGUNA NIGUEL, Calif., Dec. 12, 2011  Inspiration Biopharmaceuticals, Inc. ... Company,s two lead hemophilia development programs - IB1001, a ... clinical trials for the treatment and prevention of ... an intravenous recombinant porcine factor VIII (FVIII) product, ...
... MALVERN, Pa., Dec. 11, 2011   TetraLogic Pharmaceuticals , ... drugs to treat cancer, today announced the oral presentation ... TL32711 at the 53rd ASH Annual Meeting and Exposition ... of Texas M. D. Anderson Cancer Center, demonstrated that ...
Cached Medicine Technology:Inspiration Biopharmaceuticals Presents Key Scientific Data from its Two Lead Hemophilia Development Programs at the 53rd Annual Meeting of the American Society of Hematology (ASH) 2Inspiration Biopharmaceuticals Presents Key Scientific Data from its Two Lead Hemophilia Development Programs at the 53rd Annual Meeting of the American Society of Hematology (ASH) 3Inspiration Biopharmaceuticals Presents Key Scientific Data from its Two Lead Hemophilia Development Programs at the 53rd Annual Meeting of the American Society of Hematology (ASH) 4Inspiration Biopharmaceuticals Presents Key Scientific Data from its Two Lead Hemophilia Development Programs at the 53rd Annual Meeting of the American Society of Hematology (ASH) 5TetraLogic Pharmaceuticals Announces Oral Presentation on Smac Mimetic TL32711 at American Society of Hematology (ASH) Annual Meeting 2
(Date:5/2/2015)... Southlake, TX (PRWEB) May 02, 2015 ... of skin laxity issues of the face, neck ... a new concept with real potential for the ... published by the ThermiHealth Clinical Advisory Council, ThermiGyn’s ... MD, FACOG, FACS, ACGE, concluded that ThermiGyn’s temperature ...
(Date:5/1/2015)... 02, 2015 IDLife LLC, a health ... to announce the addition of its newest partner and ... life long athlete, growing up in gymnastics and competitive ... by becoming a personal trainer and helping others achieve ... of several TV shows highlighting her stunning physique and ...
(Date:5/1/2015)... CA (PRWEB) May 01, 2015 Jusuru ... Award for the successful repositioning of its flagship nutritional ... company brand with a new name, new logo, new ... DSA Ethos Awards are designed to identify and promote ... its best. , “DSA congratulates Jusuru International for ...
(Date:5/1/2015)... TROY Healthcare Solutions is proud to be ... (RUG) Conference in Atlanta, GA from May 6 – ... provides a forum for client-to-client presentations, continuing education credits, ... electronic medical record operations, as well as showcasing member ... addition to sponsoring the event, TROY Healthcare Solutions will ...
(Date:5/1/2015)... 01, 2015 Ernst & Young (EY) ... Rosenthal, Co-Founder & CSO, and Burak Sezen, Co-Founder & ... EY Entrepreneur Of The Year® 2015 Awards in ... is a global leader in assurance, tax, transaction ... one of the top audit companies in the world. ...
Breaking Medicine News(10 mins):Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3Health News:IDLife LLC Announces New Partnership with Fitness Celebrity, Jen Widerstrom 2Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 3Health News:RowdMap, Inc. Named as a Ernst & Young Entrepreneur Of The Year® 2015 Award Finalist 2
... 17 Issues on the forefront of HIV prevention research ... (M2010) at the David L. Lawrence Convention Center in Pittsburgh ... investigators, clinicians, policy makers, community advocates and experts in global ... and in all parts of the world. Nearly 1,000 participants ...
... fewer lifesaving services, survey shows , MONDAY, May 17 (HealthDay ... a new poll reveals that more than two-thirds of emergency ... , The survey -- conducted by e-mail -- also finds ... for incoming patients down the road. , The current snapshot ...
... ... of the most effective ways to burn calories and increasing cardiovascular and respiratory fitness. Why ... well as shaping your glute, legs, and stomach muscles like inline skating. , ... Chicago, IL (PRWEB) May 17, 2010 -- ...
... ... a positive way. ,“Conflicts in the Workplace: Sources & Solutions” is a new and ... put aside differences, control their emotions, and move forward., , ... (PRWEB) May 17, 2010 -- Kantola Productions ...
... ... pets are fragile and susceptible to injury. , ... (Vocus) May 17, 2010 -- Trupanion, a pet health insurance ... A small Yorkshire Terrier, Felix, is insured with Trupanion and recently broke his leg ...
... ... awards 519 nursing homes the profession’s best-in-class, Excellence in Action award. This honor recognizes ... or workforce satisfaction levels that fall within the top ten percent of My InnerView’s ... Wausau, ...
Cached Medicine News:Health News:Press briefings at International Microbicides Conference May 22-25 2Health News:Press briefings at International Microbicides Conference May 22-25 3Health News:Press briefings at International Microbicides Conference May 22-25 4Health News:Press briefings at International Microbicides Conference May 22-25 5Health News:ER Docs Predict Jump in Emergency Room Visits 2Health News:Fight Obesity with Fitness Entrepreneur's New Product That Makes Inline Skating Safer 2Health News:Kantola Productions Releases Conflict Resolution Training Video 2Health News:Trupanion Emphasizes the Importance of Pet Insurance for Small Pets 2Health News:‘Best in Class' Nursing Homes Recognized for Exemplary Customer, Workforce Satisfaction 2Health News:‘Best in Class' Nursing Homes Recognized for Exemplary Customer, Workforce Satisfaction 3Health News:‘Best in Class' Nursing Homes Recognized for Exemplary Customer, Workforce Satisfaction 4Health News:‘Best in Class' Nursing Homes Recognized for Exemplary Customer, Workforce Satisfaction 5Health News:‘Best in Class' Nursing Homes Recognized for Exemplary Customer, Workforce Satisfaction 6Health News:‘Best in Class' Nursing Homes Recognized for Exemplary Customer, Workforce Satisfaction 7Health News:‘Best in Class' Nursing Homes Recognized for Exemplary Customer, Workforce Satisfaction 8Health News:‘Best in Class' Nursing Homes Recognized for Exemplary Customer, Workforce Satisfaction 9Health News:‘Best in Class' Nursing Homes Recognized for Exemplary Customer, Workforce Satisfaction 10Health News:‘Best in Class' Nursing Homes Recognized for Exemplary Customer, Workforce Satisfaction 11Health News:‘Best in Class' Nursing Homes Recognized for Exemplary Customer, Workforce Satisfaction 12Health News:‘Best in Class' Nursing Homes Recognized for Exemplary Customer, Workforce Satisfaction 13Health News:‘Best in Class' Nursing Homes Recognized for Exemplary Customer, Workforce Satisfaction 14Health News:‘Best in Class' Nursing Homes Recognized for Exemplary Customer, Workforce Satisfaction 15
... From Medtronic, Inc., the leader in beating ... Positioner. The new Starfish NS device is ... to broaden patient acceptance of surgical revascularization.,The ... Perform the Multi-Vessel Small Thoracotomy (MVST) ...
... system is a key component ... CAB procedures. This expertly crafted ... mounting options. The unique rail ... blade configurations as well as ...
... Guidant's fourth generation access device - XPOSE ... the heart. The XPOSE 4 Device is ... off-pump bypass surgery and to easily position ... Designed for both apical and non-apical placement ...
... fit in tight spaces easily? Introducing ... - the latest innovation in mechanical ... equipped with low-profile feet, innovative FlexLink ... greater reach, maneuverability, and access to ...
Medicine Products: